High Level of HSF1 Associates With Aggressive Endometrial Carcinoma and Suggests Potential for HSP90 Inhibitors

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2014.262
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PIK3CA Amplification Associates With Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association With PI3K Inhibition

Clinical Cancer Research
Cancer ResearchOncology
2013English

Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition

Oncotarget
Oncology
2013English

Cytosolic HSP90 Associates With and Modulates the Arabidopsis RPM1 Disease Resistance Protein

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2003English

Studies of Potential Inhibitors of Sodium Aluminosilicate Scales in High-Level Waste Evaporation

Separation Science and Technology
FiltrationProcess ChemistryChemical EngineeringSeparationChemistryTechnology
2008English

Hsp90 Inhibitors in Oncology: Ready for Prime Time?

Current Oncology
Oncology
2014English

Coexistence of Endometrial Mesonephric-Like Adenocarcinoma and Endometrioid Carcinoma Suggests a Müllerian Duct Lineage: A Case Report

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2019English

The Krüppel-Like Factor 9 (KLF9) Network in HEC-1-A Endometrial Carcinoma Cells Suggests the Carcinogenic Potential of Dys-Regulated KLF9 Expression

Reproductive Biology and Endocrinology
GynecologyEndocrinologyReproductive MedicineDevelopmental BiologyObstetrics
2008English

Development of a High-Throughput Screening Cancer Cell-Based Luciferase Refolding Assay for Identifying Hsp90 Inhibitors

Assay and Drug Development Technologies
Drug DiscoveryMolecular Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy